- Home
- MGRC vs OGN Comparison
MGRC vs OGN Comparison
Compare MGRC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRC
- OGN
- Stock Information
- Founded
- MGRC 1979
- OGN 1923
- Country
- MGRC United States
- OGN United States
- Employees
- MGRC N/A
- OGN N/A
- Industry
- MGRC Diversified Commercial Services
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- MGRC Consumer Discretionary
- OGN Health Care
- Exchange
- MGRC Nasdaq
- OGN Nasdaq
- Market Cap
- MGRC 2.9B
- OGN 2.5B
- IPO Year
- MGRC N/A
- OGN N/A
- Fundamental
- Price
- MGRC $124.02
- OGN $9.44
- Analyst Decision
- MGRC Buy
- OGN Hold
- Analyst Count
- MGRC 2
- OGN 4
- Target Price
- MGRC $145.50
- OGN $18.00
- AVG Volume (30 Days)
- MGRC 130.6K
- OGN 4.8M
- Earning Date
- MGRC 07-24-2025
- OGN 08-05-2025
- Dividend Yield
- MGRC 1.56%
- OGN 0.85%
- EPS Growth
- MGRC 117.49
- OGN N/A
- EPS
- MGRC 10.26
- OGN 2.69
- Revenue
- MGRC $941,536,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- MGRC $6.30
- OGN N/A
- Revenue Next Year
- MGRC $5.24
- OGN $1.02
- P/E Ratio
- MGRC $12.08
- OGN $3.51
- Revenue Growth
- MGRC 8.78
- OGN N/A
- 52 Week Low
- MGRC $95.50
- OGN $8.01
- 52 Week High
- MGRC $129.93
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- MGRC 58.65
- OGN 49.73
- Support Level
- MGRC $117.69
- OGN $9.15
- Resistance Level
- MGRC $122.75
- OGN $9.48
- Average True Range (ATR)
- MGRC 2.80
- OGN 0.45
- MACD
- MGRC -0.05
- OGN 0.03
- Stochastic Oscillator
- MGRC 96.79
- OGN 56.14
About MGRC McGrath RentCorp
McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.